United States· US:0591-4385_89783971-3346-4ff8-ac47-d824a7ddf75d
Fosaprepitant
A medicinal product containing fosaprepitant dimeglumine, registered in United States by Actavis Pharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FOSAPREPITANT DIMEGLUMINE
- Manufacturer
- Actavis Pharma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1105914385791 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)
- ndc110591-4385-79
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fosaprepitant dimeglumine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFosaprepitant AccordAccord Healthcare B.V.
- BelgiumIvemend 115 mgMerck Sharp & Dohme
- CzechiaIVEMENDMerck Sharp & Dohme B.V., Haarlem
- IrelandIvemend 150 mg Powder for solution for infusionMerck Sharp & Dohme BV,
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Spain · Fosaprepitant Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af946b91-87e6-4147-8430-980a3c0fc3a6 GET /v1/drugs/af946b91-87e6-4147-8430-980a3c0fc3a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "150",
"substance": "FOSAPREPITANT DIMEGLUMINE",
"productndc": "0591-4385",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA210064",
"marketing_category": "NDA"
}See everything about fosaprepitant dimeglumine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.